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Abstract
Systematic reviews of diagnostic test accuracy summarize the accuracy, e.g. the sensitivity and speciﬁcity, of diagnostic tests in a systematic and
transparent way. The aim of such a review is to investigate whether a test is sufﬁciently speciﬁc or sensitive to ﬁt its role in practice, to compare
the accuracy of two or more diagnostic tests, or to investigate where existing variation in results comes from. The search strategy should be
broad and preferably fully reported, to enable readers to assess the completeness of it. Included studies usually have a cross-sectional design in
which the tests of interest, ideally both the index test and its comparator, are evaluated against the reference standard. They should be a
reﬂection of the situation that the review question refers to. The quality of included studies is assessed with the Quality Assessment of
Diagnostic Accuracy Studies-2 checklist, containing items such as a consecutive and all-inclusive patient selection process, blinding of index test
and reference standard assessment, a valid reference standard, and complete veriﬁcation of all included participants. Studies recruiting cases
separately from (healthy) controls are regarded as bearing a high risk of bias. For meta-analysis, the bivariate model or the hierarchical summary
receiver operating characteristic model is used. These models take into account potential threshold effects and the correlation between
sensitivity and speciﬁcity. They also allow addition of covariates for investigatation of potential sources of heterogeneity. Finally, the results from
the meta-analyses should be explained and interpreted for the reader, to be well understood.
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Introduction
Practising evidence-based medicine starts with a clinical
question [1]. For example, a general physician might want to
know whether testing for papilloma virus can replace cytology
for the diagnosis of cervical cancer, as it is cheaper and easier
to perform, or a haematologist might wonder whether a
molecular test is needed on top of clinical judgement before a
patient is treated for invasive fungal diseases. For questions
such as these, the sensitivity and speciﬁcity of a diagnostic test
may be helpful.
Systematic reviews are at the heart of evidence-based
medicine. These literature overviews are performed in a
systematic and transparent way, and they are explicit about
where their study base comes from and how included
references were selected. The quality of included studies is
assessed and, if appropriate, the results are quantitatively
summarized in a meta-analysis. These explicit methods limit
bias, and improve the reliability of conclusions [2]. Systematic
reviews also enable us to establish whether ﬁndings are
consistent and can be generalized over different situations.
Healthcare professionals looking for evidence about diag-
nostic tests may turn to systematic reviews of diagnostic test
accuracy. These reviews summarize the sensitivity and spec-
iﬁcity of a test, and sometimes other measures as well, such as
predictive values, likelihood ratios, ORs, or summary receiver
operating characteristic (ROC) curves [3]. Sensitivity is
deﬁned as the probability of a person with the disease of
interest having a positive test result, and speciﬁcity is deﬁned
as the probability of a person without the disease having a
negative test result. These refer to the clinical situation in
ª2013 The Author
Clinical Microbiology and Infection ª2013 European Society of Clinical Microbiology and Infectious Diseases
REVIEW 10.1111/1469-0691.12474
which a test is being used, and are different from analytical
sensitivity (referring to the ability of the test to measure low
concentrations of a substance) and analytical speciﬁcity (usually
referring to cross-reactivity). They may also be different from
more technical deﬁnitions of sensitivity and speciﬁcity, such as
the ability to distinguish between cases and (often healthy)
controls. These analytical and technical measures are impor-
tant in the earlier phases of test development, whereas clinical
sensitivity and speciﬁcity are used to indicate the performance
of a test in clinical practice [4].
The number of diagnostic test accuracy reviews has rapidly
increased, especially over the last 5 years. A quick MEDLINE
search revealed that the number of systematic reviews or
meta-analyses with diagnosis, diagnostic, test, testing, tests or
accuracy in the title grew from 748 at the end of 2008 to 2068
in November 2013. However, readers ﬁnd it difﬁcult to grasp
the concept of a diagnostic test accuracy review, and this may
limit their use in practice [5].
This overview describes the steps involved in a diagnostic
test accuracy systematic review, while focusing on the link with
the clinical question. We hope to explain for readers what they
can expect from a diagnostic accuracy review, and how the
results of these reviews can be used in clinical and laboratory
practice. A selection of 20 diagnostic test accuracy reviews in
infectious diseases will serve as an illustration [6–25] (see
Appendix). These reviews come from a set of reviews
published between September 2011 and January 2012 that
we used to survey which meta-analytic methods authors use
[26].
Review question
The ﬁrst and most important step in a systematic review is
question formulation. The review question guides the rest of
the review: it dictates the relevant study design and study
characteristics, the potential biases to be expected, the
appropriate meta-analysis technique, and the interpretation of
results. The review question includes some basic elements:
the patients or population who will undergo the test in
practice, the test(s) of interest and comparator test(s), and
the target condition or disease of interest, as deﬁned by the
reference standard. When papilloma virus testing is com-
pared with cytology, the patient population consists of
women who will be tested for cervical cancer. The test of
interest is called the index test, here being virus testing. Its
comparator in this case is cytology. The disease of interest is
cervical cancer; the term target condition refers to a more
speciﬁc deﬁnition, e.g. a speciﬁc stage of cancer, or treatable
cancer [27].
A key element in diagnostic accuracy is the reference
standard. This is the test used to deﬁne the target condition,
and the underlying assumption is that it reﬂects the truth. For
cervical cancer, a valid reference standard is histopathology. By
design, the reference standard is assumed to be ﬂawless. The
reference standard sets the reference, and sensitivity and
speciﬁcity are expressed as the proportion of reference
standard positives with a positive index test result, and the
proportion of reference standard negatives with a negative
index test result, respectively. It is therefore impossible to
show that an index test is better than the reference standard,
even if this would be the case in reality.
To place the review question in a context and to enable
better interpretation of the results, the place of the test(s) in
the diagnostic pathway should be described [28]. It matters
whether the test is used as a ﬁrst-line test to decide who should
be referred for further testing, or whether the test will be used
to start treatment on the basis of the test result. If a test is used
as a ﬁrst-line test, then the composition of the sample and the
consequences of a false-positive or false-negative test result will
be different from those in a more specialized situation. A
ﬁrst-line test, also called a triage test, may be useful even when
the sensitivity or speciﬁcity is not high, depending on the steps
that will be taken after testing. If the test is used to determine
who should be treated and who should not be treated, it will be
important to not miss any diseased patients (requiring high
sensitivity), and it may be also be important to prevent the
treatment of non-diseased persons (requiring high speciﬁcity),
especially when the treatment is invasive or burdensome. A
systematic review on molecular assays for neonatal sepsis aimed
to investigate whether the sensitivity of these assays would be
higher than 98% and the speciﬁcity higher than 95%, based on
the balance between missing almost no neonate with sepsis and
overtreatment of neonates without sepsis [19]. Authors may
ﬁnd it difﬁcult to ﬁrmly state a minimally accepted sensitivity and
speciﬁcity beforehand. Alternatively, one could hypothesize that
the sensitivity and speciﬁcity in the current study should at least
be as high as previously reported, or that the sensitivity and
speciﬁcity of the index test should at least be as high as those of
the comparator test(s).
An important secondary objective of a diagnostic test
accuracy review is to investigate potential sources of heter-
ogeneity. How do the sensitivity and speciﬁcity of a test differ
between adults and children, or between primary care and
secondary care, or between different subtypes of the test? For
example, the objective of a systematic review on antigen tests
for tuberculosis was to estimate the diagnostic accuracy of
antigen detection tests using different clinical specimens in
adults and children with and without human immunodeﬁciency
virus infection [9].
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Sometimes, a review states that it aims to ‘characterize the
clinical usefulness’ [13] or to assess the ‘immunodiagnostic
efﬁcacy’ [24]. These terms refer to outcome measures other
than accuracy measures. A test with very high sensitivity and
speciﬁcity is not necessarily useful or effective: if patient
management does not change after a test result, then testing
does not inﬂuence the patient’s outcome. Therefore, phrasing
the aim and objective in terms of usefulness or efﬁcacy may
confuse the readers.
Searching for Literature
For systematic reviews, the aim of a search strategy is often to
ﬁnd all available evidence that can be used to answer a
particular question [29]. Therefore, the search strategy should
be as broad as possible. Although missing a random number of
studies does not necessarily inﬂuence the summary estimates,
the credibility of a systematic review may depend on the
search strategy used. This search strategy should incorporate
an electronic search, checking reference lists of relevant
studies and reviews, and some effort should be put in the
retrieval of unpublished data (grey literature).
For systematic reviews, at least two electronic bibliographic
databases should be searched, such as MEDLINE, EMBASE
(which includes MEDLINE), or BIOSIS. These databases can be
accessed through a search engine, e.g. OVID (for MEDLINE or
EMBASE) or PubMed (for MEDLINE). The development of a
broad search strategy requires a wide variety of search terms,
combined in a way that is not restrictive. In general, review
authors are encouraged to use all existing synonyms for the
target condition and all synonyms for the index test(s), and
sometimes also for the class of tests that the index test
belongs to. A broad search strategy includes these terms both
as medical subject heading (if available) and as words in the title
or abstract of a study. Medical subject headings are terms that
are linked to a certain topic, and studies are indexed in the
bibliography by use of these headings. However, indexing may
not be perfect, and adding the same or similar terms as words
in the title or abstract therefore increases the number of
retrieved studies. Similarly, a strategy that focused only on
words in titles or abstracts would miss studies not using these
exact words, and medical subject headings may retrieve such a
study.
Depending on the topic, the search may result in >5000
titles [10,19]. To limit these numbers, some authors use terms
such as ‘sensitivity and speciﬁcity’ or ‘accuracy’, so-called
methodological search ﬁlters [8,14]. Diagnostic accuracy
studies are all described in different ways; there is no standard
terminology. This is especially true for older studies, which
makes it difﬁcult to ﬁlter these studies or to index them. The
use of search ﬁlters may therefore lead to relevant studies
being missed, and so is not recommended [29,30]. Achieving a
balance between manageable numbers and being as complete
as possible is a complex task that requires support from
information specialists.
Readers should be able to assess the likelihood that relevant
studies were missed. This is only possible if the search strategy
has been reported completely, including all terms used and the
way in which these terms were used (as subject headings, or as
words in titles and abstracts). Although word count limits may
discourage authors to do so, most journals have online
supplements or online appendices in which the complete
search strategy may be reported.
Selection of Relevant Studies
The ﬁrst step in the selection process is the selection of
potentially relevant publications on the basis of title and
abstract. Then, the full texts of these articles are read and
included when deemed relevant. The last stage is the exclusion
of studies that turn out to be not relevant when data are
extracted. In every stage, the selection is performed by two
individuals independently. Although the value of independent
double selection over selection by one author has not been
investigated, the complexity of diagnostic test accuracy studies
suggests the need for selection by at least two review authors.
Two major diagnostic test accuracy designs may be distin-
guished. One is the so-called diagnostic case–control or
two-gate design, in which the people with the disease (cases)
are selected from a different population than the persons
without the disease (controls) [31]. For example, people with
malaria may be selected in a ﬁeld health centre, whereas
controls without malaria may be selected from among stored
blood samples from donors without any infections. Although
case–control designs provide an indication of the maximum
accuracy of a test, and are therefore valuable in the technical
validation of a test, estimates from these studies are generally
not representative of a test’s accuracy in clinical practice [32,33].
The alternative design is a more cohort-like approach, a
typical cross-sectional design in which all patients suspected of
having the disease of interest undergo the index test(s). To
verify who has the disease and who does not, all included
patients also undergo the reference standard test. The
reference standard-positive patients can be seen as cases,
and the reference standard-negative patients can be seen as
controls. Such a design reﬂects reality better than the case–
control design, and is more likely to provide valid estimates of
diagnostic accuracy.
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A review may include both case–control designs and
cross-sectional designs. In that case, the potential for bias
caused by the case–control studies should be assessed [18].
Another disadvantage of case–control design studies is that
prevalence or predictive values cannot be estimated. The
positive (or negative) predictive value is calculated by dividing
the true-positive (or negative) results by all positive results (or
negative results). Both prevalence and predictive values
depend on the ratio of people with and without the disease.
In case–control studies, this ratio is constructed artiﬁcially, and
thus prevalence and predictive values calculated from such a
study are artefacts.
If the aim of the review is to compare two or more tests,
then, ideally, cross-sectional designs evaluating both tests
against the same reference standard and in the same patients
should be included. However, these studies are rare, and
limiting the selection to only these comparative studies may
result in no included studies at all. Non-comparative studies
evaluate one of the tests of interest, and are far more
common, but may also lead to a biased comparison [34]. If the
studies evaluating test A against a reference standard were all
performed in severely ill patients and all studies evaluating
test B against a reference standard were performed in patients
who were not that ill, then the difference between test A and
test B may have been caused by the difference in setting rather
than being a real difference between the tests.
Assessment of Methodological Quality
A number of studies have shown that diagnostic accuracy is
not a ﬁxed property of a test, although we may have been
taught otherwise [35–37]. It varies, depending on where the
study was performed, in which patients it was performed, how
the test was performed, and whether the study was ﬂawed.
Risk of bias refers to a ﬂawed study design and systematic
errors in the conduct of the study. Applicability refers to
clinical variation: studies performed in specialized clinics may
not be applicable when the review is focused on primary-care
questions. If the included studies are biased or not applicable
to the situation in practice, the results from the review should
be taken with caution. Most diagnostic accuracy reviews use
the Quality Assessment of Diagnostic Accuracy Studies
(QUADAS) tool, or its revision, QUADAS-2 [38,39]. It
assesses the quality of included studies in terms of risk of
bias and concerns regarding applicability over four domains, as
discussed below.
Patient selection may be biased when a case–control design is
used, or when patients who may be difﬁcult to diagnose are
excluded from the study. Concerns regarding applicability arise
when the patients in the study are not the same as those
tested and used in practice. For example, when the study had
no risk of bias, but included a combination of adults and
children, and the review focuses on children, there may be a
concern regarding applicability. The test may behave differently
in adults and in children.
The index test may be biased when the assessment takes
place while the assessors know the diagnosis or reference
standard results of the patients, or when the threshold or
cut-off value at which the results are reported was selected
ad hoc. Concerns regarding applicability may also depend on
the threshold used in the study. For example, if, in practice,
most laboratories would use one threshold, but an included
study uses a different threshold, then this may lead to concerns
regarding applicability even if this threshold was deﬁned
beforehand.
The reference standard may be biased when the reference
standard is assessed with knowledge of the index test results
or when it is likely that the reference standard does not
correctly classify the target condition. Concerns regarding
applicability arise when the reference standard used in the
study deﬁnes a different disease or target condition than the
target condition of the review.
The fourth domain is ﬂow and timing, and it refers to the
time interval between the index test and the reference
standard, and whether patients have been treated in the
meantime. It also refers to the ﬂow of testing: were all patients
subjected to all index tests and the (same) reference standard?
The last part of this domain concerns the analyses: for
example, when studies exclude uninterpretable or intermedi-
ate results when calculating sensitivity and speciﬁcity, the
accuracy may be overestimated.
Quality assessment results are presented in a graph or a
table, and may be used to investigate the effect of bias on the
results. Sometimes, reviews limit their analyses to high-quality
studies only, but this often leads to there being too few studies
in the review for any analyses to be performed [40]. Deﬁning
high quality is also problematic. Some review authors calculate
an overall quality score and set a threshold to deﬁne high
quality [21]. This is not recommended, as some sources of bias
may be more inﬂuential than others, and this may differ
between topics [41].
Data Analysis
The analysis of the data starts with a description of the
included studies and their accuracy results: the number of
studies retrieved, the number of diseased and non-diseased
participants included, and the main characteristics (setting,
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year, etc.). Accuracy results from the individual studies can be
described in the same table, in a forest plot, or in a plot of
sensitivity vs. 1 – speciﬁcity. Other accuracy measures may
also be presented: predictive values, likelihood ratios, and
ORs. Although any outcome can be meta-analysed, we will
focus on sensitivity and speciﬁcity. The main reason for this is
that any other measure can be calculated on the basis of these
estimates, whereas it may not be possible to calculate valid
measures of sensitivity and speciﬁcity the other way around
[42].
A meta-analysis is a quantitative method that uses the
results from the included studies to estimate a weighted
average. Systematic reviews may contain a meta-analysis, but
this is not a requirement. Sometimes, the data are too scarce
or too heterogeneous. A key feature of diagnostic test
accuracy and an important factor in the meta-analysis of these
data is the threshold effect. Continuous tests require a
threshold above (or below) which the test is considered to be
positive. For example, all test results above a value of
150 units/mL are regarded as positive. If a higher value of
the test correlates with more symptoms or a higher likelihood
of the disease, then increasing the threshold will lead to more
false-negative results (and thus lower sensitivity) and fewer
false-positive results (and thus higher speciﬁcity). If the
included studies use different thresholds, then the sensitivity
and speciﬁcity will also be different between these studies. The
threshold effect is the most obvious source of heterogeneity in
an accuracy review.
Because sensitivity and speciﬁcity depend on the situation in
which the test is being used, and because of the threshold
effect, sensitivity and speciﬁcity are expected to be very
heterogeneous. In combination with the correlation between
sensitivity and speciﬁcity, this makes testing for heterogeneity
or using the I-square statistic to indicate the degree of
heterogeneity problematic. The review on cervical cancer
reported an I-square of 85.6% for the speciﬁcity of cytology for
cervical cancer [11]. Although this indicates that there is much
heterogeneity in speciﬁcity, this heterogeneity may be largely
caused by the variation in sensitivity or by a threshold effect.
Rather than testing whether heterogeneity is present, authors
are therefore encouraged to investigate where the heteroge-
neity comes from.
The dependence on threshold and the correlation between
sensitivity and speciﬁcity also has implications for the
meta-analysis. Methods are needed that can deal with heter-
ogeneity, with threshold effects, and with the correlation
between sensitivity and speciﬁcity. The Cochrane Collabora-
tion currently recommends two random-effects methods: the
bivariate model, and the hierarchical summary ROC (HSROC)
model [43–45]. The bivariate model meta-analyses a summary
estimate for sensitivity and speciﬁcity together (Fig. 1a),
whereas the HSROC model models the parameters for the
summary ROC curve (Fig. 1b). In general, the HSROC model
is recommended for continuous tests when the included
studies all report a different threshold for test positivity. The
bivariate model is recommended for purely binary tests or
when different studies report similar thresholds.
These models can also be used to investigate sources of
heterogeneity. For example, a review on antigen detection
tests for tuberculosis estimated the accuracy of these tests in
both adults and children and in people with and without human
immunodeﬁciency virus infection [9]. In this review, the
authors separately analysed the data for all subgroups
(subgroup analysis). Other ways to investigate heterogeneity
(a) (b)
FIG. 1. Summary receiver operating characteristic (ROC) plots. (a) Summary sensitivity and speciﬁcity (red square) and their 95% conﬁdence
region (dotted ellipse). (b) Summary ROC curve (solid line) and summary point (red square). Every circle represents the sensitivity and speciﬁcity
estimate from one study, and the size of the circle reﬂects the sample size. The graphs were made in StataIC 10, based on data from Onishi et al.
[18].
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are the removal of certain subgroups from the overall analyses
(sensitivity analysis), or the inclusion of variables as covariates
in the meta-analyses. Both the HSROC model and the bivariate
model allow the addition of covariates. In the HSROC model,
covariates may explain the variation in accuracy, threshold or
shape of the ROC curve. In the bivariate model, covariates
may explain variation in sensitivity and speciﬁcity. Of the 20
reviews in the Appendix, 11 used either the HSROC or the
bivariate model.
A comparison between two tests can be performed by
treating these tests as a source of heterogeneity, by meta-anal-
ysing the two tests separately (subgroup analysis), or by adding
test type as a covariate to the bivariate or HSROC model. If
both comparative studies and non-comparative studies are
included in the analyses, it may be worthwhile performing a
sensitivity analysis to assess the effect of the comparative
studies on the overall analyses [34].
An important threat to the validity of a systematic review is
publication bias. Publication bias occurs if studies with
favourable results are more likely to be published than studies
with unfavourable results. Although there is no evidence of
publication bias in diagnostic accuracy reviews, it seems
unlikely that it does not exist at all. Methods to detect
publication bias are not very reliable when used in diagnostic
accuracy data, although the method of Deeks et al. has been
shown to be the least biased [46]. An alternative is to compare
conference abstracts with published work [47].
Interpretation and Conclusions
Interpretation of the results of the review and the concluding
remarks should refer back to the review question and the
(potential) role of the index test in clinical practice. Readers
ﬁnd it difﬁcult to grasp the implications of the estimated
sensitivity and speciﬁcity, and should be guided towards better
understanding. Key to this explanation is the role of the test in
practice and the potential consequences of a positive test
result and a negative test result.
As a start, the main results could be presented in a summary
of ﬁndings table, e.g. like the table presented by Kattenberg et al.
[10]. In this table, the absolute numbers of true positives, false
positives, false negatives and true negatives may be given for a
hypothetical cohort of 1000 people. In the review on molecular
tests for neonatal sepsis, the hypothetical cohort may exist of
1000 neonates screened for early-onset sepsis [19]. The
expected prevalence of early-onset sepsis in this group is 2%.
This means that 20 neonates will have sepsis. An assay with a
sensitivity of 90% and a speciﬁcity of 96% would miss two of 20
cases with sepsis, and would lead to overtreatment in 39 of 980
neonates without sepsis (Fig. 2). These numbers may facilitate
the interpretation of accuracy results, especially in the case of a
comparative question, where the numbers for one test can be
compared with the numbers for its alternative(s). Although high
sensitivity and speciﬁcity do not necessarily lead to better health
for the patient, putting the results in a clinical context and
combining the clinical context with hypothetical numbers may
provide more insights into the relevant consequences for the
false-positive patients and the false-negative patients.
Results from the meta-analysis should also be interpreted in
the light of their validity. If the majority of included studies are
case–control designs, the actual accuracy will probably be
lower than the estimates from the meta-analysis. This should
be emphasized. The same is true for the other sources of bias
and heterogeneity.
Transparency Declaration
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1000 neonates
(prevalence 2%)
20 neonates
with sepsis
980 neonates
without sepsis
Molecular test:
Sensitivity = 90%
Specificity = 96%
Positive Negative
0.90 × 20 = 18 true positives
0.04 × 980 = 39 false positives
0.10 × 20 = 2 false negatives
0.96 × 980 = 941 true negatives
They will be treated
with antibiotics
They will not be
treated with antibiotics
FIG. 2. Consequences of a molecular test for neonatal sepsis in a
hypothetical cohort of 1000 neonates. The use of this test will, on
average, mean that of 57 neonates treated with antibiotics, 39 do not
have sepsis, and of 943 neonates who will not be treated with
antibiotics, two should have been treated after all [19].
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Sensitivity: proportion of persons tested positive amongst those
having the target condition, TP/(TP+FN).
Speciﬁcity: proportion of persons tested negative amongst those
without the target condition, TN/(TN+FP).
Prevalence: proportion of persons with the target condition amongst
the group suspected of having the condition, (TP+FN)/
(TP+FP+FN+TN).
Positive predictive value: proportion having the target condition
amongst those tested positive, TP/(TP+FP).
Negative predictive value: proportion not having the target condition
amongst those tested negative, TN/(TN+FN).
Positive likelihood ratio: ratio of the proportion of positives amongst
those with the target condition compared to the proportion of
positives amongst those without the target condition, sensitivity/
(1-speciﬁcity).
Negative likelihood ratio: ratio of the proportion negatives amongst
those with the target condition compared to the proportion
negatives amongst those without the target condition, (1-sensitiv-
ity)/speciﬁcity.
Diagnostic odds ratio: ratio of the odds of testing positive when having
the target condition compared to the odds of testing positive
without the target condition, (TP/FN):(FP/TN).
Receiver characteristic operating (ROC) curve: the sensitivity and
speciﬁcity of a test vary depending on the threshold chosen. The
ROC curve describes the trade-off between sensitivity and
speciﬁcity as the threshold changes.
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